Particle.news
Download on the App Store

Investors Mobilize in Commvault Securities Suit Over Alleged ARR Misstatements

Multiple plaintiff firms are urging shareholders to seek lead‑plaintiff status before a July 17 deadline to determine whether the case advances to discovery or draws regulatory scrutiny.

Overview

  • The litigation follows Commvault's Jan. 27, 2026 disclosure that Q3 net new ARR was $39 million versus a $45 million target, a miss that triggered an about 31% one‑day share price drop and prompted investor complaints.
  • Complaints say company statements between April 29, 2025 and Jan. 26, 2026 failed to disclose that a rising mix of lower‑priced, heavily discounted SaaS deals and longer‑term contracts would materially depress reported ARR growth.
  • At least one federal suit is pending in the District of New Jersey and several plaintiff firms including Rosen, Hagens Berman, Frank R. Cruz, Bernstein Liebhard and Levi & Korsinsky are soliciting class members and vying to be named lead plaintiff.
  • The case is at an early procedural stage with a July 17, 2026 lead‑plaintiff filing deadline; if a lead plaintiff is appointed the litigation could move to document discovery, depositions, whistleblower tips and possible SEC interest.
  • Annualized recurring revenue (ARR) is a core valuation metric for SaaS firms and can fall even when subscriptions grow if average selling prices drop, which plaintiffs say explains investor losses and underlies potential damages and settlement claims.